Hemab Therapeutics Holdings, Inc.
Research Hemab Therapeutics Holdings, Inc. (COAG) on Bullrun: market cap USD 1.48B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCOAG
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.48B
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 24.15M
- Free cash flow-USD 22.66M
Valuation Snapshot
latest market cap is USD 1.48B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 63.91M | -USD 61.49M | n/a | -2.33 | USD 87.97M | USD 1.22M | -USD 176.64M |
| FY2024 | USD 0 | -USD 48.71M | -USD 45.87M | n/a | -1.77 | USD 74.41M | USD 1.73M | -USD 115.27M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 1.48B | n/a | n/a | n/a |
About Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hemab Therapeutics Holdings, Inc.'s market cap?
Hemab Therapeutics Holdings, Inc.'s market capitalization is USD 1.48B.
What does Hemab Therapeutics Holdings, Inc. do?
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark.